The role involves taking national leadership of the Hemophilia, VWD, and HAE portfolio with full ownership of strategic launches like Hemgenix and Andembry.
Not specified; Includes options for life insurance and retirement plans; Two additional leave days provided
Must-have
Nice-to-have
Not specified